Pergolide treatment in parkinsonism. 1983

J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010479 Pergolide A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES. Celance,LY-127,809,LY-127809,Parkotil,Pergolide Mesylate,Permax,Pharken,LY127,809,LY127809,Mesylate, Pergolide
D012120 Respiration Disorders Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available. Disorder, Respiration,Disorders, Respiration,Respiration Disorder
D004873 Ergolines A series of structurally-related alkaloids that contain the ergoline backbone structure. Ergoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
April 1999, Journal of neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
August 1983, Neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
August 2002, Rinsho shinkeigaku = Clinical neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
May 1985, Neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
January 1995, Journal of neural transmission. Supplementum,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
December 1983, Clinical endocrinology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
January 1984, Advances in neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
March 1995, Neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
July 1984, Neurology,
J Ilson, and S Fahn, and R Mayeux, and L J Cote, and S R Snider
April 1991, The American journal of the medical sciences,
Copied contents to your clipboard!